Axon/$AXON

1D1W1MYTD1Y5YMAX

About Axon

Axon Enterprise Inc is building a public safety operating system by integrating a suite of hardware devices and cloud software solutions. The company's suite includes cloud-hosted digital evidence management solutions, TASER energy devices, drones and robotic security, and training solutions. Its operation comprises of two operating segments, Software and Services, and Connected Devices. The company generates the majority of its revenue from the Connected Devices segment, which is engaged in developing, manufacturing, and selling fully integrated hardware solutions such as conducted energy devices sold under the TASER brand, body cameras, fixed and in-car cameras, drone and counter-drone technologies, and a broad ecosystem of accessories, extended warranties and related hardware products.
Ticker
$AXON
Primary listing
NASDAQ
Employees
5,100

Axon Metrics

BasicAdvanced
$37B
188.61
$2.40
1.40
-

What the Analysts think about Axon

Analyst ratings (Buy, Hold, Sell) for Axon stock.
Analyst projections of the future price of Axon stock.

Bulls say / Bears say

Q2 revenue rose 35% to $904 million, while Axon raised its 2026 growth outlook to 32%–34%. Annual recurring revenue grew 39% to $1.6 billion, net revenue retention reached 126%, and future contracted bookings rose 41% to $15.1 billion. (Axon Enterprise)
The product ecosystem is broadening beyond body cameras and TASER devices. Newer software offerings grew roughly 70% together, AI Era revenue grew nearly 700%, and platform solutions revenue rose 123%, giving Axon more opportunities to cross-sell higher-value tools. (Axon Enterprise, Last10K)
Axon is expanding into international, enterprise, federal and emergency-response markets rather than relying only on US local police departments. International and enterprise bookings each roughly tripled year on year, while the company secured its first full-scope Axon 911 agreement and was selected for a $1.5 billion US counter-drone programme. (Axon Enterprise, The Lincolnian Online)
The shares still price in strong execution. Recent coverage put Axon at roughly 11–13 times trailing revenue, and the stock fell 9.8% after the company announced a $1 billion zero-coupon convertible offering, highlighting dilution and funding concerns. (Trefis, Simply Wall St)
Cash and reported profit remain weaker than the adjusted figures suggest. Q2 GAAP net income fell to $29 million, free cash flow was slightly negative, stock-based compensation was $144 million in the quarter, and higher memory costs plus the loss of a tariff refund are expected to pressure near-term margins. (Axon Enterprise, TS2)
The business depends heavily on public-sector budgets and customer acceptance of surveillance and AI tools. Axon warns that contracts can be cancelled or not renewed because of non-appropriation, while a recent Covington deal faced privacy objections and required extra reporting controls. (Axon Enterprise, WVXU)
Data summarised monthly by Lightyear AI. Last updated on 17 Sept 2026.

Axon Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Axon Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.